 BEVERLY HILLS, Calif., Sept. 15, 2021 PRNewswire -- GT Biopharma, Inc. the Company NASDAQ: GTBP, a clinical stage immuno-oncology company focused on developing innovative therapeutics based on the Companys proprietary natural killer NK cell engager, TriKE protein biologic technology platform, today announced that Jeffrey Miller, MD, University of Minnesota Medical School, Professor of Medicine, Division of Hematology, Oncology and Transportation will present a mini-oral presentation at the European Society for Medical Oncology ESMO Congress 2021 to be held virtually September 16-21. 